Issue link: https://viewer.e-digitaledition.com/i/580312
Phillips says. "However, when you look at the age of these survivors, the magnitude of these morbidities at relatively young ages is quite striking. Typically, you would not expect many of these morbidities to be problems in the general population until much older ages." Developing a Clinical Path Forward Cancer treatment-related morbidities place a variety of physical, develop- mental, cognitive, psychosocial and financial burdens on survivors and their families. The challenge for medicine is to devise ways to better mitigate those burdens to allow survivors to thrive. " W h i le t here h a v e b e en m a ny advances in lifesaving treatments for childhood cancer, these treatments are not without consequences," Phillips says. "This is a population experienc- ing co-occurring treatment benefits a nd morbidit y. Due to their young age at diagnosis and their longevity, the consequences of these morbidities have implications for both the survivors themselves and the healthcare system." "This study showed that for child- hood cancer sur vivors, conquering cancer is not the end of their medical challenge; rather, they have suscepti- bilities to multiple chronic conditions," says Lynne Padgett, PhD, Program Director of the Basic Biobehavioral and Psychological Sciences Branch of the Behavioral Research Program at the National Cancer Institute of the National Institutes of Health. Padgett is a co-author of the study. "It is impor- tant that primary care physicians … are aware of their patients' histories of childhood cancer and that these individuals may need to be screened for chronic disease morbidities earlier than we might otherwise expect." ■ S U RV E Y I N G C H I L D H O O D C A N C ER S ' L AT E EFFEC TS CONDITIONS RELATED TO chemotherapy, radiotherapy or surgery for pediatric cancer may emerge months or years after treatment concludes. The nature and severity of late effects are infl uenced by a number of factors, including the indi- vidual's gender and genetic composition, the type of cancer, the location of cancer in the body, and the type of treatment. "Unfortunately, for a subset of survivors, the cost of their cure can often be very signifi cant," says Jill P. Ginsberg, MD, Director of the Cancer Survivorship Program in the Division of Oncology at The Children's Hospital of Philadelphia. "Some survivors develop second malignancies, whereas others are at risk for organ toxic- ity, such as cardiac or renal dysfunction. Endocrinopathies, such as hypothyroidism or growth hormone defi ciency, can also be found in a subset of patients treated with neck irradiation or cranial irradiation, respectively. Some survivors struggle with infertility or premature ovarian failure as a result of their therapy. Survivors who have had stem cell transplants or those who have been treated for brain tumors are often the most impacted by long-term effects of their therapy." Cancer treatment can also result in psychological sequelae, including post- traumatic stress disorder, according to Dr. Ginsberg. "It is imperative that cancer survivors receive appropriate psychological assessment for any signs of cancer-related distress, as well as to monitor for other psychosocial issues that may exist," Dr. Ginsberg says. "Research has docu- mented that children treated with intensive chemotherapy or radiation therapy, particularly at a young age, are at risk for cognitive diffi culties in the months and years following treatment. This risk makes it critical to document academic perfor- mance and potential for neurocognitive defi cits so that appropriate interventions can be introduced." SPECIAL CLINICAL SECTION: CHRONIC CARE M D N E W S . CO M ■ MD NEWS Lower Hudson Bronx | 1 5

